외래수술센터(ASC) 시장 : 시술 유형별, 시설 유형별, 수술실 수용 능력, 지불자 유형별, 용도, 소유 형태별 - 세계 시장 예측(2026-2032년)

The Ambulatory Surgical Centers Market is projected to grow by USD 176.40 billion at a CAGR of 9.67% by 2032.

Ambulatory Surgical Centers Executive Summary

Ambulatory surgical centers (ASCs) are becoming a core delivery model for modern outpatient surgery as payers, providers, and patients prioritize clinically appropriate lower-acuity procedures in efficient, specialized settings. The sector benefits from advances in minimally invasive surgery, anesthesia, digital scheduling, infection-control protocols, and value-based reimbursement that support safe same-day discharge across a growing range of procedures.

Publicly available policy and utilization signals from CMS, OECD health systems, WHO resources, and national payer programs confirm a durable shift away from inpatient care where clinically appropriate. For health systems and investors, the ambulatory surgical centers landscape is defined by site-of-service migration, physician alignment, operational productivity, regulatory compliance, and patient experience, making ASCs one of the most strategically important segments in outpatient healthcare delivery.

Transformative Shifts in the ASC Landscape

The ASC landscape is being reshaped by the movement of orthopedic, ophthalmology, gastroenterology, pain management, urology, and selected cardiovascular procedures into outpatient environments. CMS payment rules, commercial payer site-of-care policies, improved anesthesia protocols, and hospital capacity pressures continue to reinforce the business case for high-quality, lower-cost ambulatory surgery.

At the same time, ambulatory surgical centers are evolving from single-specialty facilities into more sophisticated multi-specialty platforms. Competitive operators are investing in revenue cycle automation, case-cost analytics, digital patient engagement, supply standardization, infection prevention, and clinical governance to balance procedure growth with margin discipline, patient safety, and accreditation requirements.

Cumulative Impact of Artificial Intelligence on ASCs

Artificial intelligence is beginning to influence the ASC value chain through predictive scheduling, automated prior authorization support, clinical documentation improvement, inventory forecasting, claims-denial prevention, and post-operative monitoring. These applications address persistent operational constraints, including block-time utilization, staffing shortages, denial management, implant cost variability, and patient follow-up adherence.

AI adoption in ambulatory surgical centers is expected to be cumulative rather than sudden. FDA-cleared AI-enabled medical devices, electronic health record analytics, computer vision, robotic workflow tools, and remote monitoring platforms will increasingly support decision-making, but leaders must maintain strong governance around patient privacy, cybersecurity, model validation, bias monitoring, clinical accountability, and clinician oversight.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

North America remains the most mature ASC region, led by the United States, where Medicare ASC payment policies, commercial payer steering, physician ownership models, accreditation standards, and high outpatient procedure volumes support scale. Canada remains more hospital-centric, yet provincial efforts to address surgical backlogs continue to encourage expanded use of community-based and independent surgical facilities for appropriate elective procedures.

Europe shows steady outpatient surgery adoption, particularly in health systems focused on reducing inpatient bed pressure, shortening elective care waiting lists, and improving day-case procedure performance. Asia-Pacific is expanding as private healthcare investment, medical tourism, urban hospital capacity constraints, and rising middle-class demand support day-surgery capacity in China, India, Japan, South Korea, Australia, and major Southeast Asian markets.

Latin America is gaining momentum through private-sector investment in Brazil and Mexico, supported by demand from insured, employer-sponsored, and self-pay populations. The Middle East is building premium ambulatory care assets as part of broader healthcare modernization, insurance expansion, and medical tourism strategies. Africa remains earlier-stage, with adoption concentrated in urban private healthcare markets where specialist availability, infrastructure, accreditation practices, and reimbursement pathways are improving.

Key Group Insights: ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are advancing ASC adoption through private hospital networks, medical tourism, and demand for accessible elective procedures, particularly in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. GCC countries are using healthcare diversification strategies, compulsory or expanding insurance systems, and public-private participation to build ambulatory surgical capacity and reduce dependence on hospital-based care.

The European Union supports outpatient surgery growth through health-system efficiency mandates, quality reporting, workforce optimization, and investment in specialized care models. BRICS countries present high-volume opportunities due to large populations, expanding private healthcare access, and rising demand for cataract, endoscopy, orthopedic, gynecologic, and minimally invasive procedures, although reimbursement consistency and infrastructure readiness remain uneven across member markets.

G7 markets lead in clinical standards, technology integration, payer-driven site-of-care optimization, and adoption of digital health tools that improve scheduling, documentation, and post-operative monitoring. NATO member countries overlap significantly with advanced European and North American health systems, where resilience planning, workforce shortages, elective backlog management, and digital health modernization reinforce demand for efficient outpatient surgical capacity.

Key Country Insights Across Major ASC Markets

The United States anchors global ASC activity through a mature reimbursement framework, broad specialty participation, established accreditation processes, and strong physician-investor alignment. Canada is focused on reducing wait times through selective use of independent and community surgical capacity, while Mexico and Brazil are expanding private ambulatory surgery services for insured, employer-sponsored, medical tourism, and self-pay populations.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are promoting day-surgery pathways to ease hospital pressure, reduce elective backlogs, and improve throughput for appropriate procedures. Russia's market is influenced by regional healthcare investment, public-private care variation, and access differences, with opportunities tied to modernization of surgical infrastructure, specialist availability, and outpatient care pathways.

China and India offer strong long-term potential due to population scale, rising incomes, expanded private healthcare networks, and policy emphasis on improving access beyond tertiary hospitals. Japan, Australia, and South Korea are more mature outpatient care environments, supported by advanced technology adoption, aging populations, established specialist capabilities, and sustained demand for cataract surgery, endoscopy, orthopedics, pain procedures, and minimally invasive interventions.

Actionable Recommendations for ASC Industry Leaders

Industry leaders should prioritize procedure-line economics, payer contracting, physician alignment, patient acquisition, and clinical governance before expanding ASC capacity. High-performing centers use service-line analytics to identify cases that can be safely migrated from hospitals while protecting quality outcomes, contribution margins, patient satisfaction, and accreditation performance.

Operators should also strengthen digital infrastructure, including interoperable scheduling, automated eligibility verification, prior authorization workflows, denial prevention, implant-cost tracking, infection surveillance, and patient communication platforms. Strategic partnerships with hospitals, payers, device suppliers, anesthesia groups, and post-acute care providers can improve throughput, reduce leakage, support compliance, and demonstrate measurable value in increasingly scrutinized outpatient settings.

Research Methodology

This executive summary is based on a structured review of public regulatory, reimbursement, clinical, and macroeconomic sources, including CMS policy materials, FDA digital health guidance, OECD health indicators, WHO health-system data, national health service publications, payer policy trends, accreditation guidance, and peer-reviewed literature on outpatient surgery safety, utilization, and quality outcomes.

The analysis applies triangulation across demand drivers, procedure migration patterns, reimbursement frameworks, technology adoption, workforce constraints, regional healthcare infrastructure, and documented policy shifts. Insights were validated for strategic relevance to ambulatory surgical centers, including ownership models, specialty mix, cost-to-serve dynamics, patient access, regulatory compliance, and policy-driven site-of-care transformation.

Conclusion

Ambulatory surgical centers are positioned for sustained relevance as healthcare systems seek lower-cost, high-quality surgical delivery outside the inpatient hospital environment. The strongest opportunities will come from centers that combine clinical excellence, payer alignment, physician engagement, patient-centered design, disciplined operational execution, and transparent outcomes measurement.

AI, analytics, automation, and digital patient engagement will further enhance ASC productivity, but technology will not replace the need for rigorous governance, infection control, workforce planning, cybersecurity, accreditation readiness, and clinical oversight. The future of ambulatory surgical centers will be shaped by operators that can scale outpatient surgery safely while demonstrating measurable value to patients, payers, providers, and health systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Ambulatory Surgical Centers Market, by Procedure Type

• 7.1. Diagnostic
• 7.2. Therapeutic

8. Ambulatory Surgical Centers Market, by Facility Type

• 8.1. Multi-Specialty
• 8.2. Single Specialty

9. Ambulatory Surgical Centers Market, by Operating Room Capacity

• 9.1. Five Or More
• 9.2. One To Two
• 9.3. Three To Four

10. Ambulatory Surgical Centers Market, by Payer Type

• 10.1. Medicaid
• 10.2. Medicare
• 10.3. Private Insurance
• 10.4. Self-Pay

11. Ambulatory Surgical Centers Market, by Application

• 11.1. Dental Surgery
• 11.2. Dermatology
• 11.3. Ent
• 11.4. Gastroenterology
• 11.5. Gynecology
• 11.6. Ophthalmology
• 11.7. Orthopedics
• 11.8. Pain Management
• 11.9. Plastic Surgery
• 11.10. Urology

12. Ambulatory Surgical Centers Market, by Ownership

• 12.1. Corporate Owned
• 12.2. Hospital Owned
• 12.3. Physician Owned

13. Ambulatory Surgical Centers Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Ambulatory Surgical Centers Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Ambulatory Surgical Centers Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Ambulatory Surgical Centers of America, LLC
• 17.2. American Surgical Group
• 17.3. AmSurg Corp.
• 17.4. Aspen Surgery Center
• 17.5. Canadian Ambulatory Surgery Centres Inc.
• 17.6. Community Health Systems, Inc.
• 17.7. Endeavor Health, LLC
• 17.8. Envision Healthcare
• 17.9. HCA Healthcare, Inc.
• 17.10. HealthCare Appraisers, Inc.
• 17.11. Healthway Medical Corporation Limited
• 17.12. Japanese Red Cross Medical Center
• 17.13. Koninklijke Philips N.V.
• 17.14. Medical Facilities Corporation
• 17.15. NextGen Healthcare, Inc.
• 17.16. Olympus Corporation
• 17.17. Oracle Corporation
• 17.18. Pediatrix Medical Group
• 17.19. QHCCS, LLC
• 17.20. Ramsay Sante SA
• 17.21. Regent Surgical Health
• 17.22. SurgCenter Development, LLC
• 17.23. Surgery Partners, Inc.
• 17.24. Symbion, LLC
• 17.25. TeamHealth, Inc.
• 17.26. Tenet Healthcare Corporation
• 17.27. The University of Tokyo Hospital
• 17.28. UnitedHealth Group Inc.
• 17.29. ValueHealth LLC